(Q30358635)

English

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.

scientific article

Statements

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer. (English)
Ignace B Vergote
Charles Pippitt
Johanna Bendell
Paula M Fracasso
Emad N Ibrahim
Vincent A Armenio
Christine Gennigens
Abraham C F Leung
Raoudha Soufi-Mahjoubi

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit